Industry and vendors
Dr Monica Trujillo argues the recent OpenAI Medicare breach shows AI governance must keep pace in healthcare (opens in a new tab)
She says oversight must become a strategic necessity as AI reaches core clinical work.
Edition of Friday 6 November 2026.
Australia
A quiet news day, so this list includes some earlier stories. Check the dates.
Primary care and general practice
A licensing dispute between Heidi and Best Practice over AI agents is a fight over who controls GP patient data (opens in a new tab)
The Medical Republic says the stoush also covers specialists and which tools may access their data, and is far from over.
The Conversation outlines how to use ChatGPT before a medical appointment, warning chatbot advice can cause serious patient harm (opens in a new tab)
It notes chatbot advice is easy to get, personalised and can be clarified with follow-up prompts.
Regulation and safety
Cancer Institute NSW seeks legal advice on keeping AI mammography software in use after its ARTG listing was cancelled (opens in a new tab)
The TGA says it has no specific safety concerns about the software.
Industry and vendors
Heidi to lay off 18 per cent of staff worldwide, and CEO Dr Thomas Kelly apologises (opens in a new tab)
The company says it will redirect spending to building its product and entering new markets.
Yu Liu and Waleed Mussa step back from Heidi Health weeks after it reached a $1.26 billion valuation (opens in a new tab)
World
A quiet news day, so this list includes some earlier stories. Check the dates.
United States
Mayo Clinic Platform launches an AI chatbot that helps clinicians with diagnosis and care decisions in 35+ specialties (opens in a new tab)
It answers clinicians' questions using Mayo's own medical knowledge base.
Wolters Kluwer survey: only about a quarter of consumers strongly trust automated drug-interaction checks without a clinician (opens in a new tab)
Comfort broke down whenever automated decisions took the place of human oversight, the survey found.
FDA and CMS officials work to head off a state-federal clash over regulating AI tested in clinical settings (opens in a new tab)
STAT says growing state interest in clinical AI trials risks a regulatory logjam.
Rest of the world
NICE drafts guidance allowing five AI prostate cancer imaging tools in the NHS during a two-year evidence period (opens in a new tab)
Named tools include Siemens' AI-Rad Companion Prostate MR and DeepHealth Prostate.
Health New Zealand's first Clinical AI Academy brought 27 participants together for three days in Wellington (opens in a new tab)
Topics included AI in surgery prep, radiology referrals and diabetes.